GLP-1 Hair Loss: Why It Happens and What Labels Say
GLP-1 hair loss on Zepbound, Mounjaro, Wegovy and Ozempic: what labels report, telogen effluvium after fast weight loss, and user reports. Not medical advice.
Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →
Short answer
The current US Zepbound label reports hair loss in 4% to 5% of trial participants vs 1% on placebo and says it was associated with weight reduction; the Wegovy label also lists hair loss above placebo. The Mounjaro (diabetes) label lists alopecia only among postmarketing reports. The usual explanation is telogen effluvium: diffuse shedding that can follow rapid weight loss, calorie restriction or physical stress, typically appearing a few months after the trigger and often improving over months. It is not thought to be a direct drug toxicity to hair follicles. Low protein, iron or other nutrient intake during reduced eating can contribute. Persistent or patchy loss deserves medical review. Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.
Hair loss on labels, by drug
From US prescribing information. Last reviewed October 15, 2026.
Why shedding happens and when it stops
Hair grows in cycles. A major stress, such as fast weight loss or a big drop in calories and protein, can push many follicles into the resting phase at once. Two to four months later they shed together, often noticed in the shower or on a brush. This telogen effluvium usually stops within about six months of weight stabilising, and regrowth follows. Thyroid problems, iron deficiency and pattern hair loss can look similar, so blood tests can help.
What confessions describe
#43 lost about a third of their hair density over five months on semaglutide; their doctor blamed the rapid weight loss, and hair partly returned after switching to a slower titration. #722 found shedding worse on tirzepatide than on another compound. Stories, not rates; unapproved compounds are not recommended here.
What people discuss to limit it
Commonly discussed measures are adequate protein, checking iron and vitamin D with a clinician, avoiding extremely rapid loss, and gentle hair care. Evidence that supplements prevent GLP-1 shedding is limited. For peptide claims see copper peptides for hair.
What users report here
Anonymous accounts are collected on the Tirzepatide reports. They are personal stories, often with other compounds in the mix, not evidence of effect.
Related topics
related peptides:
community guides:
More confessions from the archive
Community Q&A
- When does GLP-1 hair loss start?
- Telogen effluvium typically shows two to four months after the trigger, so shedding often starts a few months into rapid weight loss.
- Does Mounjaro cause hair loss?
- The Mounjaro label lists alopecia among postmarketing reports; the Zepbound label (same molecule) reports 4–5% vs 1% on placebo, linked to weight reduction.
- Does Zepbound cause hair loss?
- Yes. The US label reports hair loss in 4% to 5% of trial participants vs 1% on placebo, associated with weight reduction.
- Is GLP-1 hair loss permanent?
- Telogen effluvium usually improves over months once weight stabilises, though individual experiences vary.
- Does this page give dosing advice?
- Peptide Confessions does not publish dosing, timing, injection or sourcing guidance.
Sources
Anonymous first-hand reports plus sourced context — educational only, not medical advice. Editorial policy & corrections.